When someone takes a GLP-1 agonist such as Ozempic or Wegovy, the drug activates the same receptors as the natural hormone, leading to better blood sugar control, reduced appetite, and weight loss
How does Ozempic work and what is it used for
our next section will answer some of the frequently asked questionsto further assist you in learning about Semaglutide (Wegovy)
At the 2026 Science Journalists Conference held at the Korea Science and Technology Center on the 28th, Professor Oh Sang-woo of the Department of Family Medicine at Dongguk University Ilsan Hospital pointed out that vulnerable populations have poor access to obesity medications
Providers assess individual risks during consultations to ensure safe treatment decisions

Medical science has made such tremendous progress that there is hardly a healthy human left. Aldous Huxley GLP-1 Agonists at a Glance First-Generation (Short-Acting) Exenatide Byetta Lixisenatide Adlyxin / Lyxumia Second-Generation (Long-Acting) Exenatide ER Bydureon (weekly, now discontinued in some markets) Liraglutide Victoza (diabetes), Saxenda (obesity) Dulaglutide Trulicity Semaglutide Ozempic (diabetes), Wegovy (obesity), Rybelsus (oral) Dual Agonist (GIP + GLP-1) Tirzepatide Mounjaro (diabetes), Zepbound (obesity) Triple or Combination Agonists (In Development) Retatrutide Triple agonist (GLP-1 + GIP + glucagon) CagriSema Combination of cagrilintide + semaglutide (GLP-1 + amylin analog) Orforglipron Oral, non-peptide GLP-1 receptor agonist (Eli Lilly) Danuglipron Oral small-molecule GLP-1 agonist (Pfizer) Efinopegdutide GLP-1/glucagon dual agonist (Merck/Biocon) AMG133 GLP-1 + GIP receptor modulator (Amgen)